Corresponding Author: Christopher W. Seymour, MD, MSc, University of Pittsburgh, Keystone Building, 3520 Fifth Ave, Ste 100, Pittsburgh, PA 15261 (seymourcw@upmc.edu).
Published Online: October 15, 2020. doi:10.1001/jama.2020.20271
Conflict of Interest Disclosures: Dr Seymour reported being supported in part by grant R35GM119519 from the National Institutes of Health; and receiving personal fees from Beckman Coulter Inc and Edwards Lifesciences Inc. No other disclosures were reported.
Additional Contributions: We acknowledge Scott Berry, PhD, and Roger J. Lewis, MD, PhD, for their input on Strategy 5.
1.Wiersinga
WJ , Rhodes
A , Cheng
AC ,
et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
JAMA. 2020;324(8):782-793.
PubMedGoogle ScholarCrossref 2.Richardson
S , Hirsch
JS , Narasimhan
M ,
et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.
JAMA. 2020;323(20):2052-2059.
PubMedGoogle ScholarCrossref 4.Taleb
N . Antifragile: Things That Gain From Disorder. Random House; 2012.
5.Stegenga
J . Medical Nihilism. Oxford University Press; 2018.
6.Arunachalam
PS , Wimmers
F , Mok
CKP ,
et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
Science. 2020;369(6508):1210-1220.
PubMedGoogle ScholarCrossref 8.Ishizaki
T , Imanaka
Y , Hirose
M ,
et al. Estimation of the impact of providing outpatients with information about SARS infection control on their intention of outpatient visit.
Health Policy. 2004;69(3):293-303.
PubMedGoogle ScholarCrossref 9.Califf
RM , Hernandez
AF , Landray
M . Weighing the benefits and risks of proliferating observational treatment assessments.
JAMA. 2020;324(7):625-626.
PubMedGoogle ScholarCrossref